Clinical Trials

Drug Development Phase 3 Trials Drug Efficacy Randomized Controlled Trials Research Studies Regulatory Approval Patient Care Phase 2 Trials Randomized Trials Regulatory Affairs

Two NEJM Trials Show Antiplatelet Monotherapy Risks Depend on Drug and Timing

New data reported at ESC Congress 2026 change how clinicians must weigh ischemic protection against bleeding risk for different P2Y12 strategies.

Moderna and Merck Report Positive Phase 3 Result for Personalized mRNA Melanoma Vaccine

SK Biopharmaceuticals Licenses Biohaven’s Opakalim in Deal Worth Up to $795 Million

Lilly Sues Six U.S. Sellers Over Black‑Market Sales of Unapproved Retatrutide

Single-Injection Gene Therapy Reverses Genetic Heart Disease in Lab Tests

One-Time Triple Regimen Clears HIV in Infant Macaque Model

Surgery Opens Two Short Windows to Deliver Drugs to Glioblastoma, Study Finds

Single Dose of Psilocybin Eases Treatment‑Resistant Depression, King’s Trial Finds

Oral Semaglutide Linked to Fewer Heavy Drinking Days in Small Randomized Trial

Wall Street Unanimously Bullish on Teva as Austedo Fuels Turnaround

NovoCure Posts Record Q2 Revenue and Raises 2026 Outlook

Vertex to Acquire Crinetics for About $10 Billion

SII and DNDi to Run International Phase III Trial of Dengue Monoclonal Antibody

First Randomized Trial Finds Ketogenic Diet Improves Metabolic Markers and Shows Early Psychiatric Signals in Psychotic Disorders

Ebola Outbreak in DRC Surges as First Antiviral Trials Begin

Moderna Repositions as Broad mRNA Company After Investor Day Rally

Pilot Trial Finds Daily Probiotics Produce Modest Drop in Depression and Anxiety in Older Adults

Novo Nordisk Confirms Cyberattack That Copied Clinical Trial Data

Lilly Wins Exclusive License to Ascidian RNA Exon-Editing Platform for Kidney Diseases

Mount Sinai Study Links Autoantibodies to Long COVID in a Subset